FeaturePosted by Alicia, April 20194 factors hindering the development of new metastasis therapies in cancer
FeaturePosted by Fiona, April 20193 reasons why procurement platforms will struggle to source the right preclinical cancer model for you
FeaturePosted by Repositive, April 2019The key factors every biopharma should consider when planning their preclinical cancer model requirements
FeaturePosted by Repositive, April 2019The 3 most common challenges when searching for preclinical cancer models
FeaturePosted by Repositive, March 2019How to overcome the challenges biopharmas face when sourcing preclinical cancer models
Press ReleasePosted by Repositive, March 2019Repositive to demonstrate how its Cancer Models Scout service can connect biopharmas with the right preclinical cancer models via an interactive app at AACR 2019
FeaturePosted by Repositive, February 2019How will drug development need to change to bring personalised cancer treatments to patients?
Press ReleasePosted by Repositive, January 2019Repositive Cancer Models Platform becomes the largest global marketplace for translational cancer models to support precision medicine
